AnesthesiaFvMinSANCT05533229
Fentanyl Versus Morphine in Spinal Anesthesia for Caesarian Section - Study on Analgesia, Side Effects and Patient 's Satisfaction
An observational study of Anesthesia, run by Dr. Mihai Octavian Botea at 1 site in Romania.
Trial summary
Intrathecal morphine and fentanyl are used for anesthesia and perioperative pain management in caesarian section. Despite the fact that spinal Fentanyl is better tolerated, might not be enough for postoperative pain control. Read more about this study
- Who is it for?
- Ages 18 to 50 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Anesthesia
- What is being tested?
- Fentanyl and Morphine
- How many people
- 160 participants
- Where
- 1 siteRomania
- Study dates
- 1 Apr 2022to 10 Aug 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 50 years
- Women only
- Healthy volunteers accepted
- Adult
Study population: The study population will be selected from the pregnant patients of Oradea Pelican Clinic Hospital.
Who may be able to join
- ASA I-II patients
- no medical past history
- not known allergies to the used medication
- no history of chronic pain ar regular use of analgesics
- no past history of anxiety or depression
- body weight ≥ 50 kg
- elective C section indication
- single fetus
Who cannot join
- conversion from a natural delivery with/without an epidural anesthesia started
- pregnant women with psychiatric disorder;
- history of drug addiction; diagnosis of acute or chronic fetal distress; contraindication of spinal anesthesia;
- patient refusal;
- preeclamptic patients, patients who developed allergic reaction after enrolling in the study;
- refusal of the pain killers or other protocol medication prescribed;
- the necessity of surgical reintervention in the next 72 h after C-section;
- previous administration of opioids and/or other central nervous system depressants.
Trial locations and contacts
1 site in 1 country.
Romania1 site
University of Oradea, Pelican Clinic Hospital
Oradea, Bihor County, 410505
About this study
Official title: Fentanyl Versus Morphine in Spinal Anesthesia for Caesarian Section - Study on Perioperative Analgesia, Side Effects and Patient 's Satisfaction
Intrathecal morphine and fentanyl are used for anesthesia and perioperative pain management in caesarian section. Despite the fact that spinal Fentanyl is better tolerated, might not be enough for postoperative pain control. Morphine offers an improved analgesia but might be not tolerated due to a higher incidence of side effects, especially nausea and vomiting.
This is a prospective, randomized, double-blind, parallel study including 80 parturients scheduled for elective CS. Spinal anesthesia is consisting in bupivacaine (7.5 - 10 mg in relation to height) and either fentanyl 25 mcg (F group) either morphine 100 mcg (m group). It will be assessed intraoperative and postoperative pain scores, the incidence of sides effects, patient's satisfaction and systemic opioids consumption.
Read the detailed description
The patients were randomly allocated into one of the two groups M (morphine) or F (fentanyl) with a sample size calculation at 1:1 ratio, using the envelope technique.
Group F (fentanyl) was administered hyperbaric bupivacaine 0.5% along with a standard dose of 25 mcg fentanyl, while group M (morphine) received hyperbaric bupivacaine 0.5% with a standard dose of 100 mcg morphine. The dose of hyperbaric bupivacaine 0.5% to be injected, was based on the patient's height and here were used a range of doses between 7.5 mg and 11 mg.
The study required two anesthetists. The first anesthetist was "in charge" and performed the spinal anesthesia and he was blind to the solution used. The second anesthetist randomly assigned the patient, drew up the intrathecal solution and provided the anesthetic mixture. By this method, the first anesthetist was totally blinded to the opioid used. All drugs were from the same manufacturer.
During the pre-anesthetic visit, the patient received information about the aims of the study, the method of anesthesia, and details about the pain management and about the pain assessment with the numeric pain scale (NPS). Patient's demographics data were obtained: height, term weight and age. Also, full medical past and drugs history, previous allergies and other important medical data were documented.
Pre-operatively a venous access was obtained with an 18 G. cannula and 500 ml of Ringer lactate solution was infused prior to anesthesia. Participants were fasting and received pantoprazol 40 mg and metoclopramide 10 mg as pre-anesthetic medication. The spinal anesthesia was performed in an aseptic technique with the patient in a sitting position, in the L3 - L4 interspace, using a midline approach, with a Whitacre 27 G. needle and the anesthetic mixture manually injected at a rate of 1 ml.15s-1, with a barbotage effect. A previous skin local anesthetic infiltration was performed with 2 ml of 1% lidocaine. After the block, the patient was placed in a supine position with a roll wedge placed under the right hip to displace the uterus to the left until fetal extraction. Volemic supply was assured with warm Ringer lactate (10-20 ml.kg-1hr-1). All patients than had anti-embolic socks on lower limbs.
Surgery started when sensory block, as assessed by the cold test, reached the T4 dermatome level.
Non-invasive blood pressure (BP) was measured every minute until the baby was delivered and every 3-5 minutes afterwards. Any decrease in systolic blood pressure below the background level resulted in intravenous ephedrine and doses of 5-15 mg being given, repeated every minute until the systolic blood pressure had been restored. At delivery, oxytocin 5 I.U. was given intravenously (normal practice when the study was conducted) and afterwards as required.
We took a proactive action to prevent the perianesthetic emetic syndrome. So, our patients received from the time of surgery a nausea prophylaxis with granisetron 1 mg and a dose o dexamethasone 4 mg. A second dose of granisetron 1 mg was given at 12 hours apart. Afterwards only as required anti-emetic medication was given.
Heart rate, BP, oxygen saturation as measured by pulse oximetry (SpO2), requirement for supplemental analgesics, need for conversion to general anesthesia were recorded intraoperatively. In addition to these parameters, the level of sensory block was assessed by the cold test, and the maximum motor block score was recorded using a 4-points Bromage scale as the complete motor recovery time.
The postoperative pain control strategy was relaying on regular paracetamol 1 gr., every 6 hrs. and ibuprophen 400 mg every 8 hrs., both drugs given in intravenous or oral administration. As required for breakthrough pain, were available doses of 50 to 100 mg. of iv. tramadol, 6 hourly to a maximum dose of 400 mg.
Data collection We collected data regarding: demographics (age, weight, height, smoke consumption, gesta/para status and preoperative contractions); time from anesthesia to incision; time to sensory block; pain scores (at surgical incision, end of surgery, at 4 h, 6 h, 12 h, 24 h, 48 h, 72 h - postoperative the pain scores were assessed at rest and on mobilizing); AUE72h (sum pain intensity differences area over 72 hours) and SPID72h (time-weighted sum pain intensity differences over 72 hours); side effects associated with anesthesia (pruritus with a grading scale, nausea, vomiting, over sedation, dizziness and respiratory depression).
Contribution to pain intensity assessment metrics Besides assessing and understanding the level of pain, pain scales help healthcare practitioners to make a well-informed and accurate diagnoses as well as to formulate carefully-considered treatment plan for their patients.
The Numeric Pain Rating Scale is a type of unidimensional pain scale which comes with numbers, from 0 to 10. A person simply needs to rate their pain based on written or verbal prompts, from 0 meaning no pain to 10 meaning worst pain imaginable.
But for a more comprehensively comparison of the post-operative pain in the study groups, two additional assessment metrics were employed:
- time-weighted sum pain intensity differences over 72 hours
- sum pain intensity differences area over 72 hours Descriptive statistics included the observed frequency counts (percentage) for categorical variables; and mean ± standard deviation for numerical variables, irrespective of their distribution. Normality was tested with the Kolmogorov-Smirnov test. For comparing means in normally distributed values, the t-test for independent samples was applied, with Levene's test for equality of variances. For comparing distribution of non-normally distributed numerical values, the non-parametric Mann-Whitney U statistical tests was applied and median (Inter-Quartile Range) with Tukey's hinges was additionally provided as a descriptive statistic.
The Chi-square statistical test (either asymptotic, Fisher's exact test, or Monte-Carlo simulation with 10,000 samples) was applied to check the statistical significance of the association between the categorical variables. The odds ratio (OR) values were calculated for the symptoms associated with the two anesthetics, such as nausea and dizziness.
The statistical analysis was conducted at a 95% level of confidence and a 5% level of statistical significance. All reported probability values were two-tailed.
Statistical analysis was performed with the statistical software IBM SPSS v. 20 and open source R v.4.0.5 packages.
Ethics The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Ethics Committees of Pelican Hospital from Oradea (no.2672/28.12.2021).
- Conditions
- Anesthesia
- Keywords
- spinal anesthesia, pain scores, spinal opioids side effects, patient's satisfaction
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
FentanylDrug
Also called plus Bupivacaine
The trial aims to study the quality of anesthesia and perioperative analgesia and patient's satisfaction provided by fentanyl and bupivacaine versus morphine and bupivacaine.
MorphineDrug
Also called plus Bupivacaine
The trial aims to study the quality of anesthesia, perioperative analgesia and patient's satisfaction provided by fentanyl and bupivacaine versus morphine and bupivacaine.
| Study group | Role | What they receive |
|---|---|---|
| Pregnant patients scheduled for C section | Spinal anesthesia Receives: Drug: Fentanyl; Drug: Morphine |
What is being measured
The primary outcome is the main question the study is designed to answer.
to assess the perioperative analgesia using Numeric Pain Scale
assessing pain scores (at surgical incision, end of surgery, at 4 h, 6 h, 12 h, 24 h, 48 h, 72 h - postoperative the pain scores were assessed at rest and on mobilization); AUE72h (sum pain intensity differences area over 72 hours) and SPID72h (time-weighted sum pain intensity differences over 72 hours); the pain scores according to the Numeric Pain Scale it will be rated between 0 and 10, meaning 0 - no pain and 10 - the worst pain imaginable
Measured: 6 months
assessing the degree of patient's of satisfaction
assessing the degree of satisfaction on a five point scale with the highest rate as being "completely satisfied", followed by "satisfied", "so so", "unsatisfied" and "completely usatisfied"
Measured: 6 months
Secondary outcomes (2)
to assess the incidence of and degree of pruritus as a side effect related to intrathecal opioids
it will be assessed the presence of pruritus and it's degree on a 4 point scale as follows: 0 - absent, 1 - minor, 2 - moderate, 3 - severe.
Measured: 6 months
to assess the incidence of other side effects related to intrathecal opioids
to assess the incidence of other side effects like: nausea, vomiting, dizziness, sedation and respiratory depression; regarding this secondary outcome measure it will be assessed as present or not during the 72 hours postoperative.
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Sep 2022
- Study start1 Apr 2022
- Primary completion1 Aug 2023
- Study completion10 Aug 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (9)Papers the sponsor has linked to this study.
- Other trials for AnesthesiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 160 participants (actual)
Sponsor and investigators
- Lead sponsor
- Dr. Mihai Octavian Botea
- Sponsor type
- University, hospital or other
- Collaborators
- Oradea Pelican Clinic Hospital
- Responsible party
- Sponsor-investigator, Dr. Mihai Octavian Botea, University of Oradea
- Investigators
- Erika Bimbo-Szuhai, MD PhD, Study chair, Head of Anesthesia Department at Oradea Pelican Clinic Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05533229
- Sponsor's protocol ID
- 07FvM_Medical Study
- Acronym
- FvMinSA
- Status last verified
- Aug 2023
- First submitted
- 10 Jul 2022
- Last updated
- 30 Aug 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Fonseca NM, Guimaraes GMN, Pontes JPJ, Azi LMTA, de Avila Oliveira R. Safety and effectiveness of adding fentanyl or sufentanil to spinal anesthesia: systematic review and meta-analysis of randomized controlled trials. Braz J Anesthesiol. 2023 Mar-Apr;73(2):198-216. doi: 10.1016/j.bjane.2021.10.010. Epub 2021 Dec 24.
PubMed 34954261Karaman S, Gunusen I, Uyar M, Biricik E, Firat V. The effects of morphine and fentanyl alone or in combination added to intrathecal bupivacaine in spinal anesthesia for cesarean section. Agri. 2011 Apr;23(2):57-63.
PubMed 21644105Weigl W, Bierylo A, Wielgus M, Krzemien-Wiczynska S, Kolacz M, Dabrowski MJ. Perioperative analgesia after intrathecal fentanyl and morphine or morphine alone for cesarean section: A randomized controlled study. Medicine (Baltimore). 2017 Dec;96(48):e8892. doi: 10.1097/MD.0000000000008892.
PubMed 29310376Seki H, Shiga T, Mihara T, Hoshijima H, Hosokawa Y, Hyuga S, Fujita T, Koshika K, Okada R, Kurose H, Ideno S, Ouchi T. Effects of intrathecal opioids on cesarean section: a systematic review and Bayesian network meta-analysis of randomized controlled trials. J Anesth. 2021 Dec;35(6):911-927. doi: 10.1007/s00540-021-02980-2. Epub 2021 Aug 2.
PubMed 34338864Cohen J. A power primer. Psychol Bull. 1992 Jul;112(1):155-9. doi: 10.1037//0033-2909.112.1.155.
PubMed 19565683Overall JE, Shobaki G, Shivakumar C, Steele J. Adjusting sample size for anticipated dropouts in clinical trials. Psychopharmacol Bull. 1998;34(1):25-33.
PubMed 9564195Stewart WC, Jackson AL, Jenkins JN. Dropout rates for intent-to-treat and per protocol analyses. Am J Ophthalmol. 2004 Apr;137(4):639-45. doi: 10.1016/j.ajo.2003.11.028.
PubMed 15059702Girgin NK, Gurbet A, Turker G, Aksu H, Gulhan N. Intrathecal morphine in anesthesia for cesarean delivery: dose-response relationship for combinations of low-dose intrathecal morphine and spinal bupivacaine. J Clin Anesth. 2008 May;20(3):180-5. doi: 10.1016/j.jclinane.2007.07.010.
PubMed 18502360Mallick-Searle T, Fillman M. The pathophysiology, incidence, impact, and treatment of opioid-induced nausea and vomiting. J Am Assoc Nurse Pract. 2017 Nov;29(11):704-710. doi: 10.1002/2327-6924.12532.
PubMed 29131554
Study at a glance
From the registry record, last updated by the sponsor on 30 Aug 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Fentanyl Versus Morphine in Spinal Anesthesia for Caesarian Section - Study on Perioperative Analgesia, Side Effects and Patient 's Satisfaction
- ClinicalTrials.gov ID
- NCT05533229
- Acronym / sponsor ID
- FvMinSA / 07FvM_Medical Study
- Conditions
- Anesthesia
- Keywords
- spinal anesthesia, pain scores, spinal opioids side effects, patient's satisfaction
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 160 participants (actual)
- Lead sponsor
- Dr. Mihai Octavian BoteaUniversity, hospital or other
- Collaborators
- Oradea Pelican Clinic Hospital
- Study start
- 1 Apr 2022 (actual)
- Primary completion
- 1 Aug 2023 (actual)
- Study completion
- 10 Aug 2023 (actual)
- First posted
- 8 Sep 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Intrathecal morphine and fentanyl are used for anesthesia and perioperative pain management in caesarian section. Despite the fact that spinal Fentanyl is better tolerated, might not be enough for postoperative pain control. Morphine offers an improved analgesia but might be not tolerated due to a higher incidence of side effects, especially nausea and vomiting.
This is a prospective, randomized, double-blind, parallel study including 80 parturients scheduled for elective CS. Spinal anesthesia is consisting in bupivacaine (7.5 - 10 mg in relation to height) and either fentanyl 25 mcg (F group) either morphine 100 mcg (m group). It will be assessed intraoperative and postoperative pain scores, the incidence of sides effects, patient's satisfaction and systemic opioids consumption.
Detailed description
The patients were randomly allocated into one of the two groups M (morphine) or F (fentanyl) with a sample size calculation at 1:1 ratio, using the envelope technique.
Group F (fentanyl) was administered hyperbaric bupivacaine 0.5% along with a standard dose of 25 mcg fentanyl, while group M (morphine) received hyperbaric bupivacaine 0.5% with a standard dose of 100 mcg morphine. The dose of hyperbaric bupivacaine 0.5% to be injected, was based on the patient's height and here were used a range of doses between 7.5 mg and 11 mg.
The study required two anesthetists. The first anesthetist was "in charge" and performed the spinal anesthesia and he was blind to the solution used. The second anesthetist randomly assigned the patient, drew up the intrathecal solution and provided the anesthetic mixture. By this method, the first anesthetist was totally blinded to the opioid used. All drugs were from the same manufacturer.
During the pre-anesthetic visit, the patient received information about the aims of the study, the method of anesthesia, and details about the pain management and about the pain assessment with the numeric pain scale (NPS). Patient's demographics data were obtained: height, term weight and age. Also, full medical past and drugs history, previous allergies and other important medical data were documented.
Pre-operatively a venous access was obtained with an 18 G. cannula and 500 ml of Ringer lactate solution was infused prior to anesthesia. Participants were fasting and received pantoprazol 40 mg and metoclopramide 10 mg as pre-anesthetic medication. The spinal anesthesia was performed in an aseptic technique with the patient in a sitting position, in the L3 - L4 interspace, using a midline approach, with a Whitacre 27 G. needle and the anesthetic mixture manually injected at a rate of 1 ml.15s-1, with a barbotage effect. A previous skin local anesthetic infiltration was performed with 2 ml of 1% lidocaine. After the block, the patient was placed in a supine position with a roll wedge placed under the right hip to displace the uterus to the left until fetal extraction. Volemic supply was assured with warm Ringer lactate (10-20 ml.kg-1hr-1). All patients than had anti-embolic socks on lower limbs.
Surgery started when sensory block, as assessed by the cold test, reached the T4 dermatome level.
Non-invasive blood pressure (BP) was measured every minute until the baby was delivered and every 3-5 minutes afterwards. Any decrease in systolic blood pressure below the background level resulted in intravenous ephedrine and doses of 5-15 mg being given, repeated every minute until the systolic blood pressure had been restored. At delivery, oxytocin 5 I.U. was given intravenously (normal practice when the study was conducted) and afterwards as required.
We took a proactive action to prevent the perianesthetic emetic syndrome. So, our patients received from the time of surgery a nausea prophylaxis with granisetron 1 mg and a dose o dexamethasone 4 mg. A second dose of granisetron 1 mg was given at 12 hours apart. Afterwards only as required anti-emetic medication was given.
Heart rate, BP, oxygen saturation as measured by pulse oximetry (SpO2), requirement for supplemental analgesics, need for conversion to general anesthesia were recorded intraoperatively. In addition to these parameters, the level of sensory block was assessed by the cold test, and the maximum motor block score was recorded using a 4-points Bromage scale as the complete motor recovery time.
The postoperative pain control strategy was relaying on regular paracetamol 1 gr., every 6 hrs. and ibuprophen 400 mg every 8 hrs., both drugs given in intravenous or oral administration. As required for breakthrough pain, were available doses of 50 to 100 mg. of iv. tramadol, 6 hourly to a maximum dose of 400 mg.
Data collection We collected data regarding: demographics (age, weight, height, smoke consumption, gesta/para status and preoperative contractions); time from anesthesia to incision; time to sensory block; pain scores (at surgical incision, end of surgery, at 4 h, 6 h, 12 h, 24 h, 48 h, 72 h - postoperative the pain scores were assessed at rest and on mobilizing); AUE72h (sum pain intensity differences area over 72 hours) and SPID72h (time-weighted sum pain intensity differences over 72 hours); side effects associated with anesthesia (pruritus with a grading scale, nausea, vomiting, over sedation, dizziness and respiratory depression).
Contribution to pain intensity assessment metrics Besides assessing and understanding the level of pain, pain scales help healthcare practitioners to make a well-informed and accurate diagnoses as well as to formulate carefully-considered treatment plan for their patients.
The Numeric Pain Rating Scale is a type of unidimensional pain scale which comes with numbers, from 0 to 10. A person simply needs to rate their pain based on written or verbal prompts, from 0 meaning no pain to 10 meaning worst pain imaginable.
But for a more comprehensively comparison of the post-operative pain in the study groups, two additional assessment metrics were employed:
- time-weighted sum pain intensity differences over 72 hours
- sum pain intensity differences area over 72 hours Descriptive statistics included the observed frequency counts (percentage) for categorical variables; and mean ± standard deviation for numerical variables, irrespective of their distribution. Normality was tested with the Kolmogorov-Smirnov test. For comparing means in normally distributed values, the t-test for independent samples was applied, with Levene's test for equality of variances. For comparing distribution of non-normally distributed numerical values, the non-parametric Mann-Whitney U statistical tests was applied and median (Inter-Quartile Range) with Tukey's hinges was additionally provided as a descriptive statistic.
The Chi-square statistical test (either asymptotic, Fisher's exact test, or Monte-Carlo simulation with 10,000 samples) was applied to check the statistical significance of the association between the categorical variables. The odds ratio (OR) values were calculated for the symptoms associated with the two anesthetics, such as nausea and dizziness.
The statistical analysis was conducted at a 95% level of confidence and a 5% level of statistical significance. All reported probability values were two-tailed.
Statistical analysis was performed with the statistical software IBM SPSS v. 20 and open source R v.4.0.5 packages.
Ethics The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Ethics Committees of Pelican Hospital from Oradea (no.2672/28.12.2021).
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Pregnant patients scheduled for C section | – | Drug: Fentanyl, Drug: MorphineSpinal anesthesia |
Who may qualify
- Ages
- 18 to 50 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- The study population will be selected from the pregnant patients of Oradea Pelican Clinic Hospital.
Key inclusion criteria (8 listed)
- ASA I-II patients
- no medical past history
- not known allergies to the used medication
- no history of chronic pain ar regular use of analgesics
- no past history of anxiety or depression
Key exclusion criteria (8 listed)
- conversion from a natural delivery with/without an epidural anesthesia started
- pregnant women with psychiatric disorder;
- history of drug addiction; diagnosis of acute or chronic fetal distress; contraindication of spinal anesthesia;
- patient refusal;
- preeclamptic patients, patients who developed allergic reaction after enrolling in the study;
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| FentanylAlso: plus BupivacaineThe trial aims to study the quality of anesthesia and perioperative analgesia and patient's satisfaction provided by fentanyl and bupivacaine versus morphine and bupivacaine. | Drug | Pregnant patients scheduled for C section |
| MorphineAlso: plus BupivacaineThe trial aims to study the quality of anesthesia, perioperative analgesia and patient's satisfaction provided by fentanyl and bupivacaine versus morphine and bupivacaine. | Drug | Pregnant patients scheduled for C section |
Primary outcome
to assess the perioperative analgesia using Numeric Pain Scale
Time frame: 6 months
assessing pain scores (at surgical incision, end of surgery, at 4 h, 6 h, 12 h, 24 h, 48 h, 72 h - postoperative the pain scores were assessed at rest and on mobilization); AUE72h (sum pain intensity differences area over 72 hours) and SPID72h (time-weighted sum pain intensity differences over 72 hours); the pain scores according to the Numeric Pain Scale it will be rated between 0 and 10, meaning 0 - no pain and 10 - the worst pain imaginable
assessing the degree of patient's of satisfaction
Time frame: 6 months
assessing the degree of satisfaction on a five point scale with the highest rate as being "completely satisfied", followed by "satisfied", "so so", "unsatisfied" and "completely usatisfied"
2 secondary outcomes
to assess the incidence of and degree of pruritus as a side effect related to intrathecal opioids
Time frame: 6 months
to assess the incidence of other side effects related to intrathecal opioids
Time frame: 6 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Aug 2023.
- Results publication: PubMed 34954261Fonseca NM, Guimaraes GMN, Pontes JPJ, Azi LMTA, de Avila Oliveira R. Safety and effectiveness of adding fentanyl or sufentanil to spinal anesthesia: systematic review and meta-analysis of randomized controlled trials. Braz J Anesthesiol. 2023 Mar-Apr;73(2):198-216. doi: 10.1016/j.bjane.2021.10.010. Epub 2021 Dec 24.
- Results publication: PubMed 21644105Karaman S, Gunusen I, Uyar M, Biricik E, Firat V. The effects of morphine and fentanyl alone or in combination added to intrathecal bupivacaine in spinal anesthesia for cesarean section. Agri. 2011 Apr;23(2):57-63.
- Results publication: PubMed 29310376Weigl W, Bierylo A, Wielgus M, Krzemien-Wiczynska S, Kolacz M, Dabrowski MJ. Perioperative analgesia after intrathecal fentanyl and morphine or morphine alone for cesarean section: A randomized controlled study. Medicine (Baltimore). 2017 Dec;96(48):e8892. doi: 10.1097/MD.0000000000008892.
- Results publication: PubMed 34338864Seki H, Shiga T, Mihara T, Hoshijima H, Hosokawa Y, Hyuga S, Fujita T, Koshika K, Okada R, Kurose H, Ideno S, Ouchi T. Effects of intrathecal opioids on cesarean section: a systematic review and Bayesian network meta-analysis of randomized controlled trials. J Anesth. 2021 Dec;35(6):911-927. doi: 10.1007/s00540-021-02980-2. Epub 2021 Aug 2.
- Results publication: PubMed 19565683Cohen J. A power primer. Psychol Bull. 1992 Jul;112(1):155-9. doi: 10.1037//0033-2909.112.1.155.
- Results publication: PubMed 9564195Overall JE, Shobaki G, Shivakumar C, Steele J. Adjusting sample size for anticipated dropouts in clinical trials. Psychopharmacol Bull. 1998;34(1):25-33.
- Results publication: PubMed 15059702Stewart WC, Jackson AL, Jenkins JN. Dropout rates for intent-to-treat and per protocol analyses. Am J Ophthalmol. 2004 Apr;137(4):639-45. doi: 10.1016/j.ajo.2003.11.028.
- Results publication: PubMed 18502360Girgin NK, Gurbet A, Turker G, Aksu H, Gulhan N. Intrathecal morphine in anesthesia for cesarean delivery: dose-response relationship for combinations of low-dose intrathecal morphine and spinal bupivacaine. J Clin Anesth. 2008 May;20(3):180-5. doi: 10.1016/j.jclinane.2007.07.010.
- Results publication: PubMed 29131554Mallick-Searle T, Fillman M. The pathophysiology, incidence, impact, and treatment of opioid-induced nausea and vomiting. J Am Assoc Nurse Pract. 2017 Nov;29(11):704-710. doi: 10.1002/2327-6924.12532.
Related trials for Anesthesia
Recruiting
NOL Guided Analgesia During Elective Laparoscopic Surgery Under General Anesthesia
Intraoperative Analgesia
RecruitingObservational study
Prevalence of Pain During Cesarean Section
Cesarean Birth
RecruitingObservational study
Pulse Wave Transit Time After Infraclavicular Block
Infraclavicular Brachial Plexus Block
RecruitingPhase 4
Propofol-Ketamine Versus Sevoflurane for Laryngeal Mask Anesthesia in Pediatric Cardiac Catheterization
Propofol, Ketamine
Recruiting
Lateral QL Block vs Intrathecal Morphine for Cesarean Section
Anesthesia, Postoperative Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Erika Bimbo-Szuhai, MD PhD study chair
Head of Anesthesia Department at Oradea Pelican Clinic Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Anesthesia, run by Dr. Mihai Octavian Botea at 1 site in Romania.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 30 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Romania. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
to assess the perioperative analgesia using Numeric Pain Scale (time frame: 6 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05533229, which also lists 9 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Aug 2023.